Journal of Blood and Lymph Disorders aims to provide a high-quality platform for the dissemination of innovative research and advancements in the fields of hematology, lymphatic disorders, and related biomedical sciences. The journal is dedicated to publishing original research, reviews, case reports, and clinical studies that enhance the understanding, diagnosis, and treatment of blood and lymphatic diseases. By fostering interdisciplinary collaboration among researchers, clinicians, and healthcare professionals, the journal strives to bridge the gap between laboratory discoveries and clinical applications, ultimately improving patient care and advancing global hematological and lymphatic health.

Lymphatic System and Disorders

Journal focuses on research related to the lymphatic system, covering both physiological and pathological aspects. It includes studies on lymphatic development, lymphangiogenesis, and the molecular mechanisms governing lymphatic function. Disorders such as lymphedema, lymphangitis, Castleman disease, and lymphatic malformations are key areas of interest. Special emphasis is placed on the role of the lymphatic system in immune response, fluid homeostasis, and cancer metastasis. By featuring cutting-edge research, we aim to provide insights into new therapeutic strategies for lymphatic disorders, including targeted molecular therapies, surgical interventions, and novel diagnostic tools.

Hematologic Malignancies

Journal actively publishes research on hematologic malignancies, including leukemia, lymphoma, and multiple myeloma. Topics covered include genetic and epigenetic alterations, novel biomarkers, and targeted therapies. We encourage submissions on advancements in chemotherapy, immunotherapy, and stem cell transplantation. Studies focusing on drug resistance, disease relapse, and patient-specific treatment approaches are also welcomed. Through a multidisciplinary approach, we aim to improve patient outcomes by facilitating a deeper understanding of cancer biology and fostering the development of innovative therapeutic strategies.

Immunohematology and Blood Transfusion

Immunohematology, a crucial aspect of transfusion medicine, is a primary focus of the journal. We publish research on blood group serology, hemolytic diseases, alloimmunization, and transfusion reactions. The journal also covers emerging trends in blood banking, donor screening, and the application of artificial blood substitutes. Special attention is given to advances in platelet and plasma therapies, pathogen reduction techniques, and personalized transfusion strategies. Our goal is to enhance patient safety and improve transfusion practices through high-impact scientific contributions.

Coagulation and Hemostasis

Journal provides an in-depth exploration of coagulation and hemostasis, including bleeding disorders such as hemophilia, von Willebrand disease, and thrombocytopenia. Studies on thrombosis, platelet function, anticoagulant therapies, and fibrinolysis mechanisms are also featured. We aim to advance the understanding of coagulation pathways, novel anticoagulants, and personalized treatment strategies. Research focusing on point-of-care testing, biomarkers for coagulation disorders, and innovative therapeutic approaches is highly encouraged. By integrating clinical and laboratory findings, the journal strives to enhance the diagnosis and management of coagulation-related conditions.

Stem Cell Research and Regenerative Medicine

With growing interest in regenerative medicine, the journal welcomes studies on hematopoietic stem cells, mesenchymal stem cells, and induced pluripotent stem cells. Research on stem cell transplantation, gene editing, and cellular therapies for hematologic and lymphatic disorders is of particular significance. We encourage investigations into stem cell biology, niche interactions, and novel expansion techniques. The journal also explores ethical considerations, clinical trials, and emerging technologies in regenerative medicine. By fostering a deeper understanding of stem cell applications, we aim to bridge the gap between basic research and clinical practice.

Infectious Diseases of Blood and Lymph

Bloodborne and lymphatic infections remain a major global health challenge, and our journal is committed to advancing research in this field. We publish studies on viral, bacterial, fungal, and parasitic infections affecting the blood and lymphatic systems. Topics include HIV, hepatitis, malaria, sepsis, and emerging infectious diseases. Research on host-pathogen interactions, immune evasion mechanisms, and antimicrobial resistance is also featured. By highlighting innovative diagnostic tools, vaccine developments, and therapeutic interventions, the journal aims to contribute to better disease management and public health strategies.

Molecular and Cellular Hematology

Understanding the molecular and cellular basis of hematologic and lymphatic disorders is essential for developing targeted therapies. The journal welcomes research on hematopoiesis, erythropoiesis, leukocyte biology, and lymphocyte function. Topics such as cytokine signaling, genetic mutations, and epigenetic modifications in blood disorders are extensively covered. We also explore advances in single-cell sequencing, CRISPR-based gene editing, and personalized medicine. By integrating molecular insights with clinical applications, the journal fosters the development of innovative diagnostic and therapeutic strategies.

Pediatric and Geriatric Hematology

Blood and lymphatic disorders manifest differently across age groups, making specialized research in pediatric and geriatric hematology crucial. The journal covers congenital disorders such as sickle cell disease, thalassemia, and primary immunodeficiencies in children. In geriatrics, we focus on age-related hematologic malignancies, anemia, and thrombosis risk. Studies on unique therapeutic challenges, supportive care, and patient-centered treatment approaches are encouraged. Our aim is to improve outcomes for both pediatric and elderly patients through evidence-based research and clinical advancements.

Experimental and Translational Hematology

Bridging the gap between basic research and clinical application is a priority for the journal. We publish studies on preclinical models, drug development, and translational research in hematology and lymphatic disorders. Emphasis is placed on novel therapeutics, biomarkers for disease prognosis, and emerging technologies such as artificial intelligence in diagnostics. The journal encourages interdisciplinary research that accelerates the transition of laboratory discoveries into clinical practice. By fostering collaboration between researchers and clinicians, we aim to drive innovation in the field of blood and lymphatic sciences.